We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Tests Improved for Detection of Helicobacter Pylori Antigen

By LabMedica International staff writers
Posted on 28 Oct 2009
Tests for the of Helicobacter pylori antigen in stool samples have been improved. More...
These tests can be used for the diagnosis and management of active H. pylori infection.

Employing a combination of amplification technology and monoclonal antibodies, two noninvasive tests can be performed using a patient stool sample. They detect H. pylori antigen with a high degree of accuracy and can be used to diagnose current infection in both adult and pediatric patients. Unlike serology methods, these stool antigen tests can be used to detect active infection and to confirm the eradication of H. pylori following antibiotic therapy.

A rapid immunochromatographic membrane-based assay provides reliable results in just 15 minutes, without the need for special equipment. Called Rapid Hp StAR, the method is suitable for small volume testing in the laboratory or for near patient testing in gastroenterology clinics and doctors offices. This makes it convenient for monitoring the efficacy of antimicrobial treatment without the need for return hospital visits.

The second test, IDEIA Hp StAR, is a sensitive and specific enzyme immunoassay. The test is easy to perform using standard equipment, allowing the "test and treat” policy recommended by the European Helicobacter Study Group (EHSG) to be implemented in routine laboratories. It is suitable for both manual and automated testing and has demonstrated good performance when compared to the urea breath test and alternative enzyme immunoassays.

The two tests are produced by Oxoid (Basingstoke, UK), a microbiology company whose products are used in laboratories to help diagnose infectious diseases. Laura Ward, marketing manager, Oxoid commented, "The Hp StAR tests provide cost effective, noninvasive alternatives to the more invasive methods offered by many hospitals. They involve minimal discomfort for the patient, making them particularly suitable for pediatric use. Furthermore, the ability to detect active infections also helps to avoid the unnecessary administration of antibiotics."

Oxoid is part of Thermo Fisher Scientific Inc. (Waltham MA, USA). Thermo Scientific offers analytical instruments as well as laboratory equipment, software, services, consumables, and reagents to enable integrated laboratory workflow solutions. Fisher Scientific has a portfolio of laboratory equipment, chemicals, supplies, and services used in healthcare, scientific research, safety, and education.

Related Links:

Oxoid
Thermo Fisher Scientific Inc.




New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Hemodynamic System Monitor
OptoMonitor
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Genai-based pathological assessment workflow for lung adenocarcinoma (Shen J. et al., Int J Surg 111(7): 4252–4262; 2025)

Generative AI Demonstrates Expert-Level Pathological Assessment of Lung Cancer

Lung adenocarcinoma is one of the most difficult cancers to diagnose accurately, requiring pathologists to spend extensive time examining tissue samples under microscopes to determine tumor grades and... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.